A detailed history of Captrust Financial Advisors transactions in Cor Medix Inc. stock. As of the latest transaction made, Captrust Financial Advisors holds 11,116 shares of CRMD stock, worth $116,606. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,116
Holding current value
$116,606
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$8.1 - $13.59 $90,039 - $151,066
11,116 New
11,116 $90,000
Q2 2022

Aug 16, 2022

BUY
$2.73 - $5.61 $488 - $1,004
179 Added 11.93%
1,679 $7,000
Q4 2021

Feb 14, 2022

SELL
$4.47 - $5.56 $697 - $867
-156 Reduced 9.42%
1,500 $7,000
Q3 2021

Nov 16, 2021

SELL
$4.46 - $7.11 $3,501 - $5,581
-785 Reduced 32.16%
1,656 $8,000
Q2 2021

Aug 16, 2021

BUY
$6.05 - $10.09 $5,693 - $9,494
941 Added 62.73%
2,441 $17,000
Q1 2021

May 17, 2021

BUY
$6.84 - $17.58 $10,260 - $26,369
1,500 New
1,500 $15,000

Others Institutions Holding CRMD

About CorMedix Inc.


  • Ticker CRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,208,200
  • Market Cap $432M
  • Description
  • CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...
More about CRMD
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.